The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer

CHEN Kai; YU Zai-cheng

Journal of Bengbu Medical University > 2013 > 37(4): 424-426.

CHEN Kai, YU Zai-cheng. The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer[J]. Journal of Bengbu Medical University, 2013, 37(4): 424-426.

Citation:

CHEN Kai, YU Zai-cheng. The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer[J]. Journal of Bengbu Medical University, 2013, 37(4): 424-426.

Citation:

CHEN Kai, YU Zai-cheng. The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer[J]. Journal of Bengbu Medical University, 2013, 37(4): 424-426.

The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer

CHEN Kai^1,2,
YU Zai-cheng^1,

1.
1. Department of Thoracic Surgical, The First Affiliated Hospital of Anhui Medical University, Hefei Anhui 230022;
2.
2. Department of Thoracic Surgical, Dingyuan County General Hospital, Dingyuan Anhui 233200, China

More Information

Received Date: August 16, 2012

Graphical Abstract

Abstract

Abstract

Objective:To investigate the clinical application value of serum thymidine kinase 1(TK1) test in the diagnosis and treatment of esophageal cancer.Methods:The TK1 level of 158 cases with esophageal cancer before operation(esophageal cancer group),40 cases with benign esophageal disease(benign disease group) and 50 healthy people(control group) were measured by enhanced chemiluminescence.In the esophageal cancer group,28 patients were randomly selected for following-up,their TK1 level were measured at 7 days and 1 month after operation.Results:The TK1 level before the operation and its positive rate in the esophageal cancer group were higher than those in the benign disease group and control group(P0.01),but the difference between the benign disease group and control group was not statistically significant(P0.05).Compared with preoperation,the TK1 levels of the 28 patients followed-up did not obviously decreased at 7 days(P0.05),but it decresed obviously in 1 month after operation in the esophageal cancer group(P0.01).Conclusions:The TK 1 test has certain clinical application value in the diagnosis,prognosis and curative effects of esophageal cancer.
- esophageal neoplasms,
- thymidine kinase 1,
- enhanced chemiluminescence

FullText(HTML)

References (18)

References

[1]	Hallek M,Touitou Y,Lvi F, et al.Serum thymidine kinase levels are elevated exhibit diurnal variations in Patients with advanced ovarian cancer[J].Clin Chim Acta,1997, 267( 2):155-166.
[1]	[2] He Q,Skog S,Wu J,et al.Existence of phosporylated and dephosphorylated forms of cytosolic thymidine kinase ( TK1 )[J].Biochim Biophys Acta,1996,1289( 1):25-30.
[2]	[3] Munch-Petersen B,Cloos L, Jensen HK, et al.Human thymidine kinase 1.Regulation in normal and malignant cells[J].Adv Enzyme Regul, 1995,35:69-89.
[3]	[4] Ke PY,Chang ZF.Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex /cyclosome-CDH1-mediated pathway[J].Mol Cell Biol,2004,24 ( 2 ): 514-526.
[4]	[5] Gronowitz SJ,Kallander FR,Diderholm H, et al.Application of an in vitro assay serum thymidine kinase:results on viral disease and malignancies in humans [J].Int J Cancer,1984,33 ( 1):5-12.
[5]	[6] Topolcan O,Holubec L Jr.The role of thymidine kinase in cancer diseases[J].Expert Opin Med Diagn,2008,2( 2):129-141.
[6]	[7] 李春海.肿瘤标志学基础与临床[M].北京:军事医学出版社,2008:153-157.
[7]	[8] Al-Madhoun A,Tjarks W,Eriksson S.The role of thymidine kinases in the activation of pyrimidine nucleoside analogues[J].Mini Rev Med Chem, 2004,4( 4):341-350.
[8]	[9] Karp G.Cell and molecular biology[M].USA:Wiley Internation Edition,2005:6699.
[9]	[10] Zhang F,Li H,Pendleton AR,et al.Thymidine kinase 1 immunoassay:a potential marker for breast cancer[J].Cancer Detect Prev,2001,25( 1):8-15.
[10]	[11] He Q,Zhang P,Zou L, et al.Concentration of thymidine kinase 1 in serum( STK1 ) is a more sensitive proliferation marker in human solid tumors than its activity[J].Oncol Rep,2005,14 ( 4):1013-1019.
[11]	[12] Arnr ES,Eriksson S.Mammalian deoxy nucleoside kinase[J].Pharmacol Ther, 1995,67( 2):155-186.
[12]	[13] 徐卫,沈秋丹,于慧,等.慢性淋巴细胞白血病患者脂蛋白脂酶和血清胸苷激酶水平及其与预后因素的相关性研究[J].中国血液学杂志,2009, 30( 1):23-26.
[13]	[14] Xu W,Cao X,Miao KR,et al.Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors[J].Int J Hematol,2009,90( 2):205-211.
[14]	[15] 曾智杰,欧阳文婷,孙艳虹,等.胸苷激酶1 在白血病患者化学治疗过程中的临床意义探讨[J].分子诊断与治疗杂志,2009,1( 1):28-31.
[15]	[16] 潘竹林,季兴英,石延敏.血清胸苷激酶水平变化在非霍奇金淋巴瘤化疗过程的临床意义[J].第二军医大学学报,2008,29( 11):1384-1385.
[16]	[17] Gronowitz JS,Hagberg H,Kllander CF, et al.The use of serum deoxythymidine kinase as a prognostic marker,and in the monitoring of patients with non-Hodgkin' s lymphoma[J].Br J Cancer,1983,47( 4):487-495.
[17]	[18] 郭林,卢仁泉.胃癌患者血清胸苷激酶检测的临床意义[J].检验医学, 2008,23( 3):271-273.

Cited By

Get Citation

XML

Article views (3116) PDF downloads (122)

Turn off MathJax

Article Contents

Abstract

References

The clinical value of serum thymidine kinase test in the diagnosis and treatment of esophageal cancer

Abstract

References

Catalog

Export File

Citation

Format

Content